| 000 -LEADER |
|---|
| fixed length control field |
01397nam a22002777a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
DMDOC |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20241015140530.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
241014b ||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9241209267 |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
|---|
| International Standard Serial Number |
0512-3054 |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
NDC |
| 086 ## - GOVERNMENT DOCUMENT CLASSIFICATION NUMBER |
|---|
| Classification number |
01332-GG |
| 110 ## - MAIN ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
World Health Organization |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
WHO expert committee on biological standardization: fifty-third report |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Geneva : |
| Name of publisher, distributor, etc. |
World Health Organization, |
| Date of publication, distribution, etc. |
2004. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
vii, 109 p. |
| 490 ## - SERIES STATEMENT |
|---|
| Series statement |
WHO Technical Report Series |
| International Standard Serial Number |
0512-3054 |
| Volume/sequential designation |
926 |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
The 53rd report of the WHO Expert Committee on Biological Standardization, convened in Geneva 2004, presents the collective expertise of international experts in the field of biological standardization. <br/>This report provides authoritative guidance on the development, production and control of biological products, including vaccines, blood products and diagnostic agents. <br/>The recommendations and guidelines outlined in this report are essential for regulatory authorities, manufacturers and researchers worldwide and will contribute to improving public health outcomes by ensuring the availability of high-quality biological products. |
| 556 ## - INFORMATION ABOUT DOCUMENTATION NOTE |
|---|
| Information about documentation note |
General |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Biological products-standards |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Vaccines-standards |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Blood |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Guidelines |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Koha item type |
Grey Literature |
| Classification part |
16.04.01 |
